| Title |
|
|
|
Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer (EORTC 75111-10114): an open-label, randomised, phase 2 trial from the Elderly Task Force/Breast Cancer Group
| |
| Author |
|
|
|
| |
| Abstract |
|
|
| | |
| Language |
|
|
|
English
| |
| Source (journal) |
|
|
|
The lancet oncology. - London | |
| Publication |
|
|
|
London : 2018
| |
| ISSN |
|
|
|
1470-2045
| |
| Volume/pages |
|
|
|
19:3(2018), p. 323-336
| |
| ISI |
|
|
|
000426466100048
| |
| Pubmed ID |
|
|
|
29433963
| |
| Full text (Publisher's DOI) |
|
|
| | |
| Full text (publisher's version - intranet only) |
|
|
| | |
|